
Wednesday, September 9, 2026 | 12:00-1:00pm EST
Fiduciary responsibility under ERISA is no longer a passive, compliance-driven exercise. New compensation disclosure requirements, increased scrutiny of PBM payment practices, and a fast-moving litigation landscape are re-shaping what plan sponsors and their service providers need to do to remain compliant with the law. Come hear our expert Panelists walk through:
- Compensation Disclosures & Prohibited Transactions – The DOL and Congress just added new requirements to law, confirming that compensation disclosures are not just limited to brokers and consultants; now, PBMs, TPAs, and other plan service providers are required to act
- PBM Transparency & Fiduciary Oversight – PBMs are now required to pass-through 100% of rebates and disclose information about the PBM's payment practices, affiliated ownership, and the cost of prescription drugs; all information that plan sponsors must now receive and review
- Voluntary Benefits Litigation – Employee-paid and "voluntary" benefit programs are drawing fiduciary scrutiny, which could spill over into major medical self-insured health plan coverage; will the courts expand ERISA's reach?
Meet the Panelists & Fiduciary Issues Subcommittee
Moderated By:
Traci McGinnis
Founder
Datavoce Consulting
SIIA Price Transparency Committee Chair
Panelists:
Herman Hofman
Partner
Varnum Law
|
Julie Selesnick
Founder & Principal
Health Plan Legal Counsel
|
Patrick Williams
Co-Founder
Fiduciary in a Box
|